As a pre-clinical contract research organisation focusing on small molecule drug discovery , SYNthesis offer a range of flexible collaborative relationships to our partners. Operating under a Fee for service (single compound or small library) or a Full Time Equivalent (Medicinal chemistry programs, Hit to lead and Lead Op) business model. SYNthesis has executed multiple research projects across many drug targets. We have a solid record of successful delivery with multiple clinical candidates from work conducted in our laboratories.